Cite

HARVARD Citation

    Reinisch, W. et al. (2021). Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease. Inflammatory bowel diseases. 27 (1), pp. 106-122. [Online]. 
  
Back to record